340 related articles for article (PubMed ID: 1881724)
1. Use of western blot and enzyme-linked immunosorbent assays to assist in the diagnosis of Lyme disease.
Rose CD; Fawcett PT; Singsen BH; Dubbs SB; Doughty RA
Pediatrics; 1991 Sep; 88(3):465-70. PubMed ID: 1881724
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of two enzyme linked immunosorbent assay methods and three Western Blot methods for the diagnosis of culture-confirmed early Lyme borreliosis in Italy.
Marangoni A; Sparacino M; Mondardini V; Cavrini F; Storni E; Donati M; Cevenini R; Sambri V
New Microbiol; 2005 Jan; 28(1):37-43. PubMed ID: 15782625
[TBL] [Abstract][Full Text] [Related]
3. Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease.
Hunfeld KP; Ernst M; Zachary P; Jaulhac B; Sonneborn HH; Brade V
Wien Klin Wochenschr; 2002 Jul; 114(13-14):580-5. PubMed ID: 12422605
[TBL] [Abstract][Full Text] [Related]
4. Antigen biochips verify and extend the scope of antibody detection in Lyme borreliosis.
Du W; Ma X; Nyman D; Povlsen K; Akguen N; Schneider EM
Diagn Microbiol Infect Dis; 2007 Dec; 59(4):355-63. PubMed ID: 17888607
[TBL] [Abstract][Full Text] [Related]
5. Comparison of four different serological methods for detection of antibodies to Borrelia burgdorferi in erythema migrans.
Olsson I; von Stedingk LV; Hanson HS; von Stedingk M; Asbrink E; Hovmark A
Acta Derm Venereol; 1991; 71(2):127-33. PubMed ID: 1675520
[TBL] [Abstract][Full Text] [Related]
6. [Serologic diagnosis of Lyme disease. A pending problem].
Guerrero A; Quereda C; Escudero R; Cobo J; Morcillo R; Martí-Belda P
Enferm Infecc Microbiol Clin; 1991; 9(6):335-8. PubMed ID: 1932240
[TBL] [Abstract][Full Text] [Related]
7. Comparison of different Borrelia burgdorferi sensu lato strains for detection of immune response in patients with erythema migrans.
Merljak Skocir L; Ruzić-Sabljić E; Maraspin-Carman V; Lotric-Furlan S; Logar M; Strle F
Int J Med Microbiol; 2008 Jul; 298(5-6):493-504. PubMed ID: 17892971
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of immunofluorescence test (IFT) and immuno (western) blot (WB) test in patients with erythema migrans.
Ruzić-Sabljić E; Maraspin V; Cimperman J; Lotric-Furlan S; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):586-90. PubMed ID: 12422606
[TBL] [Abstract][Full Text] [Related]
9. Facial nerve palsy in Lyme disease: evaluation of clinical diagnostic criteria.
Smouha EE; Coyle PK; Shukri S
Am J Otol; 1997 Mar; 18(2):257-61. PubMed ID: 9093686
[TBL] [Abstract][Full Text] [Related]
10. [Lyme borreliosis: how is it manifested in Spain?].
Guerrero A; Quereda C; Martí-Belda P; Escudero R
Med Clin (Barc); 1993 May; 101(1):5-7. PubMed ID: 8315978
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis.
Feder HM; Abeles M; Bernstein M; Whitaker-Worth D; Grant-Kels JM
Clin Dermatol; 2006; 24(6):509-20. PubMed ID: 17113969
[TBL] [Abstract][Full Text] [Related]
12. Limitation of serological testing for Lyme borreliosis: evaluation of ELISA and western blot in comparison with PCR and culture methods.
Tylewska-Wierzbanowska S; Chmielewski T
Wien Klin Wochenschr; 2002 Jul; 114(13-14):601-5. PubMed ID: 12422608
[TBL] [Abstract][Full Text] [Related]
13. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
[TBL] [Abstract][Full Text] [Related]
14. [A comparative study of western blot interpretation criteria for Lyme disease serological diagnosis in our environment].
Núñez Murillo E; Gutiérrez Fernández J; Guerrero Fernández M; Piedrola Angulo G; Maroto Vela C
An Med Interna; 1998 Jan; 15(1):8-12. PubMed ID: 9580180
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous manifestations of Lyme borreliosis.
Berger BW
Rheum Dis Clin North Am; 1989 Nov; 15(4):627-34. PubMed ID: 2685922
[TBL] [Abstract][Full Text] [Related]
16. Atypical Lyme borreliosis in an HIV-infected man.
Cordoliani F; Vignon-Pennamen MD; Assous MV; Vabres P; Dronne P; Rybojad M; Morel P
Br J Dermatol; 1997 Sep; 137(3):437-9. PubMed ID: 9349345
[TBL] [Abstract][Full Text] [Related]
17. [The polymerase chain reaction evaluation of Borrelia burgdorferi DNA presence in peripheral blood of patients with Lyme disease].
Kondrusik M; Grygorczuk S; Skotarczak B; Wodecka B; Pancewicz S; Zajkowska J; Swierzbińska R; Hermanowska-Szpakowicz T
Pol Merkur Lekarski; 2004 Dec; 17(102):593-6. PubMed ID: 15771130
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics of Lyme disease in 12 cases].
Anlar FY; Durlu Y; Aktan G; Açikgöz E; Bingöl N; Madencioğlu V; Anlar B
Mikrobiyol Bul; 2003 Oct; 37(4):255-9. PubMed ID: 14748262
[TBL] [Abstract][Full Text] [Related]
19. Development of erythema migrans in spite of treatment with antibiotics after a tick bite.
Maraspin V; Lotric-Furlan S; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):616-9. PubMed ID: 12422612
[TBL] [Abstract][Full Text] [Related]
20. Detection of serum antibodies against Borrelia burgdorferi with some commercially available serological tests.
Melby K; Steinbakk M; Jensenius M; Figenschau KJ
NIPH Ann; 1990 Dec; 13(2):37-44. PubMed ID: 2093855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
